Immutep Announces Results From Systematic Evaluation Of 5 Clinical Trials Of Eftilagimod Alfa APC Activator In Combination With Standard-Of-Care Therapies In Late-Stage Cancer Patients

Benzinga Newsdesk www.benzinga.com Positive 81.4%

Neg 0% Neu 0% Pos 81.4%

Comments

No comments yet. Be the first!